Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)

Danese, S; Vermeire, S; Hellstern, P; Panaccione, R; Rogler, G; Fraser, G; Kohn, A; Desreumaux, P; Leong, RW; Comer, GM; Cataldi, F; Banerjee, A; Maguire, MK; Li, C; Rath, N; Beebe, J; Schreiber, S

Danese, S (reprint author), Humanitas Clin & Res Ctr, Dept Gastroenterol, Via Manzoni 56, I-20089 Milan, Italy.; Danese, S (reprint author), Humanitas Univ, Via Manzoni 56, I-20089 Milan, Italy.

GUT, 2019; 68 (1): 40

Abstract

Objective N eutralising pro-inflammatory interleukin-6 (IL-6) may effectively treat Crohn's disease (CD). Effects of PF-04236921, an anti-IL-6 antibod......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索